Brief: Active Biotech Q4 operating loss narrows to SEK 13.5 mln

Active Biotech AB publ

16/02/2017 07:30

Feb 16 (Reuters) - Active Biotech Ab  ACTI.ST : 
    * Q4 net sales SEK 7.1 million versus SEK 5.0 million year 
ago 
    * Q4 operating loss SEK 13.5 million versus SEK 28.2 million 
year ago 
    * Says operations are progressing according to plan pending 
the Phase 3 results for laquinimod in the first half of 2017  
 
 
Source text for Eikon:  ID:nGNE1qnMKy  
Further company coverage:  ACTI.ST  
 
 ((Olof.Swahnberg@thomsonreuters.com;))